PHASESEQ Trademark

Trademark Overview

On Monday, January 25, 2021, a trademark application was filed for PHASESEQ with the United States Patent and Trademark Office. The USPTO has given the PHASESEQ trademark a serial number of 90485823. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 11, 2023. This trademark is owned by Transition Bio, Inc.. The PHASESEQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals; scientific research in the field of biomolecular condensate analysis
phaseseq

General Information

Serial Number90485823
Word MarkPHASESEQ
Filing DateMonday, January 25, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements

Goods and ServicesResearch and development of pharmaceuticals; scientific research in the field of biomolecular condensate analysis

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 26, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTransition Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameTransition Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10023

Trademark Events

Event DateEvent Description
Monday, December 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Sunday, November 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, November 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, November 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, November 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, November 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 3, 2023SOU EXTENSION 3 GRANTED
Wednesday, May 3, 2023SOU EXTENSION 3 FILED
Wednesday, May 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 9, 2022SOU EXTENSION 2 GRANTED
Wednesday, November 9, 2022SOU EXTENSION 2 FILED
Wednesday, November 9, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 6, 2022SOU EXTENSION 1 GRANTED
Friday, May 6, 2022SOU EXTENSION 1 FILED
Friday, May 6, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 11, 2021ASSIGNED TO EXAMINER
Monday, April 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 28, 2021NEW APPLICATION ENTERED

Related Keywords

phaseseq research condensate analysis biomolecular scientific development pharmaceuticals field